Flora Growth Stock (NASDAQ:FLGC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.56

52W Range

$0.63 - $2.93

50D Avg

$1.10

200D Avg

$1.27

Market Cap

$23.12M

Avg Vol (3M)

$114.94K

Beta

1.86

Div Yield

-

FLGC Company Profile


Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

97

IPO Date

May 11, 2021

Website

FLGC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 21
Pharmaceuticals and Nutraceuticals$2.34M

Fiscal year ends in Dec 23 | Currency in USD

FLGC Financial Summary


Dec 23Dec 22Dec 21
Revenue$76.07M$37.17M$8.98M
Operating Income$-46.67M$3.29M$-18.95M
Net Income$-57.04M$-52.63M$-21.36M
EBITDA$-45.87M$5.92M$-18.95M
Basic EPS$-7.75$-13.73$-9.72
Diluted EPS$-7.75$-13.73$-9.72

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q1 24May 15, 24 | 12:00 AM
Q2 23Aug 15, 23 | 11:59 AM
Q4 22Apr 03, 23 | 11:40 AM

Peer Comparison


TickerCompany
SNOASonoma Pharmaceuticals, Inc.
TKNOAlpha Teknova, Inc.
SBFMSunshine Biopharma, Inc.
GHSIGuardion Health Sciences, Inc.
PTPIPetros Pharmaceuticals, Inc.
INCRInterCure Ltd.
CLVRClever Leaves Holdings Inc.
PRFXPainReform Ltd.